These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 18844724
1. A potent and selective inhibitor of endocannabinoid uptake, UCM707, potentiates antinociception induced by cholestasis. Hasanein P, Javanmardi K. Fundam Clin Pharmacol; 2008 Oct; 22(5):517-22. PubMed ID: 18844724 [Abstract] [Full Text] [Related]
4. Modulation of cholestasis-induced antinociception in rats by two NMDA receptor antagonists: MK-801 and magnesium sulfate. Hasanein P, Parviz M, Keshavarz M, Javanmardi K, Allahtavakoli M, Ghaseminejad M. Eur J Pharmacol; 2007 Jan 12; 554(2-3):123-7. PubMed ID: 17107671 [Abstract] [Full Text] [Related]
6. Effects of the endocannabinoid transport inhibitors AM404 and UCM707 on diabetic neuropathy in rats. Hasanein P, Soltani N. Clin Exp Pharmacol Physiol; 2009 Nov 12; 36(11):1127-31. PubMed ID: 19413593 [Abstract] [Full Text] [Related]
7. Modulation of neuropathic and inflammatory pain by the endocannabinoid transport inhibitor AM404 [N-(4-hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide]. La Rana G, Russo R, Campolongo P, Bortolato M, Mangieri RA, Cuomo V, Iacono A, Raso GM, Meli R, Piomelli D, Calignano A. J Pharmacol Exp Ther; 2006 Jun 12; 317(3):1365-71. PubMed ID: 16510698 [Abstract] [Full Text] [Related]
9. UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide. de Lago E, Fernández-Ruiz J, Ortega-Gutiérrez S, Viso A, López-Rodríguez ML, Ramos JA. Eur J Pharmacol; 2002 Aug 02; 449(1-2):99-103. PubMed ID: 12163112 [Abstract] [Full Text] [Related]
10. Role of GABAA receptor in modulation of acute thermal pain using a rat model of cholestasis. Hasanein P, Parviz M. Pharmacol Biochem Behav; 2014 Sep 02; 124():226-30. PubMed ID: 24955862 [Abstract] [Full Text] [Related]
12. An endocannabinoid tone limits excitotoxicity in vitro and in a model of multiple sclerosis. Loría F, Petrosino S, Hernangómez M, Mestre L, Spagnolo A, Correa F, Di Marzo V, Docagne F, Guaza C. Neurobiol Dis; 2010 Jan 02; 37(1):166-76. PubMed ID: 19815071 [Abstract] [Full Text] [Related]
15. Effects of opioidergic systems upon anxiolytic-like behaviors induced in cholestatic rats. Eslimi D, Oryan S, Nasehi M, Zarrindast MR. Eur J Pharmacol; 2011 Nov 16; 670(1):180-5. PubMed ID: 21914447 [Abstract] [Full Text] [Related]
16. Activation of the endocannabinoid system as therapeutic approach in a murine model of multiple sclerosis. Ortega-Gutiérrez S, Molina-Holgado E, Arévalo-Martín A, Correa F, Viso A, López-Rodríguez ML, Di Marzo V, Guaza C. FASEB J; 2005 Aug 16; 19(10):1338-40. PubMed ID: 15941768 [Abstract] [Full Text] [Related]
17. Mechanisms of TNFalpha-induced cardiac dysfunction in cholestatic bile duct-ligated mice: interaction between TNFalpha and endocannabinoids. Yang YY, Liu H, Nam SW, Kunos G, Lee SS. J Hepatol; 2010 Aug 16; 53(2):298-306. PubMed ID: 20626112 [Abstract] [Full Text] [Related]
18. Modulation of cholestasis-induced antinociception by CCK receptor agonists and antagonists. Rastegar H, Homayoun H, Afifi M, Rezayat M, Dehpour AR. Eur Neuropsychopharmacol; 2002 Apr 16; 12(2):111-8. PubMed ID: 11872326 [Abstract] [Full Text] [Related]
19. Alteration in male reproductive system in experimental cholestasis: roles for opioids and nitric oxide overproduction. Kiani S, Valizadeh B, Hormazdi B, Samadi H, Najafi T, Samini M, Dehpour AR. Eur J Pharmacol; 2009 Aug 01; 615(1-3):246-51. PubMed ID: 19445924 [Abstract] [Full Text] [Related]